期刊文献+

抑癌基因PTEN在乳腺癌激素耐受细胞中的表达 被引量:7

Effect of PTEN on the cell growth and PI3K/AKT signal pathway in Tamoxifen-resistant breast cancer cell-line LCC2
原文传递
导出
摘要 目的探讨抑癌基因PTEN对乳腺癌Tamoxifen耐受细胞系LCC2细胞增殖和PI3K/AKT信号通路的作用。方法在乳腺癌Tamoxifen耐受细胞系LCC2中,建立PTEN蜕皮激素稳定诱导表达系统,5μmol/L松甾酮A诱导PTEN表达后,检测PTEN的表达对LCC2细胞周期和细胞凋亡的影响以及对磷酸化AKT蛋白水平的作用。结果PTEN不能诱导细胞发生凋亡,但可以使细胞停滞于G1期。对照组中G1期的细胞百分比为58.74%,S期为22.58%;诱导表达24h后G1期的细胞百分比为67.98%,S期为15.36%(P<0.05);诱导表达48h后G1期的细胞百分比为69.47%,S期为12.70%(P<0.05)。松甾酮A诱导PTEN表达24h和48h后,与对照组相比PTEN表达后活化的AKT表达减少,但是24h和48h间差异无统计学意义(P>0.05)。结论PTEN可能通过PI3K/AKT信号转导途径诱导细胞生长的抑制,使细胞停滞于G1期,但不能诱导细胞凋亡。 Objective To study the effect of tumor suppression gene PTEN on the cell growth and the PI3K/AKT signal pathway in tamoxifen-resistant breast cancer cell line with ecdysone inducible mammalian expression system. Methods Wild-type PTEN eDNA was cloned into the inducible expression vector pIND and the resulting construct with pVgRXR was cotransfected into tamoxifen-resistant breast cancer cell line LCC2. Single cell clone was generated by 600 mg/L zeocin and 750 mg/L C-418 selection. 5μmol/L Ponasterone A was used to induce expression of the PTEN gene from the inducible expression vector. The expression of phosphospecific AKT was detected by immunoblot and the cell cycle and cell apoptosis by FACS, respectively. Results After induction of ponasterone A for 24 h or 48 h, the PTEN expression in LCC2 caused cell cycle arrest at the Gl phase but not apoptosis and inhibited the expression of phosphospecific AKT. Conclusion PTEN may suppress cell growth though the inhibition of PI3K/AKT signal pathway and cause cell cycle arrest at the G1 phase but not apoptosis. These results may provide new clues on the therapy in tamoxifen-resistance breast cancer.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2005年第10期1195-1197,共3页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30170921)
  • 相关文献

参考文献4

  • 1陈剑英,张波,王国斌,郑海,陈庆勇,陈道达.人类乳腺癌基因表达分析[J].中华实验外科杂志,2005,22(4):429-431. 被引量:15
  • 2张波,陈道达,王国斌,吴毅华.雌二醇、三苯氧胺对乳腺癌和子宫内膜细胞增殖的影响[J].中华实验外科杂志,2002,19(2):139-140. 被引量:3
  • 3Li J, Yen C, Parsons R, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 1997, 275:1943-1947.
  • 4Liu H, Radisky DC, Wang F, et al. Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J Cell Biol, 2004, 164: 603-612.

二级参考文献13

  • 1陈剑英,张波,王国斌,陈道达.乳腺癌激素耐受细胞系LCC2的基因表达分析[J].中华普通外科杂志,2004,19(12):744-746. 被引量:13
  • 2Sgroi DC, Teng S, Robinson G, et al. In vivo gene expression profile analysis of human breast cancer progression. Cancer Res, 1999, 59:5656-5661.
  • 3Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tmours. Nature, 2000, 406: 747-752.
  • 4Imasato A, Desbois C, Han J, et al. Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhanced nontypeable Heamophilus influenzae-induced expression of toll-like receptor 2. J Biol Chem, 2002, 277: 47444-47450.
  • 5Efimova T, Deucher A, Kuroki T, et al. Novel protein kinase C isoforms regulate human keratinocyte differentiation by activating a p38 delta mitogen-activated protein kinase cascade that targets CCAAT/enhancer-binding protein alpha. J Biol Chem, 2002, 277:31753-31760.
  • 6Galic S, Klingler-Hoffmann M, Fodero-Tavoletti MT, et al. Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP. Mol Cell Biol, 2003, 23: 2096-2108.
  • 7Wang Q, Wang X, Evers BM. Induction of cIAP-2 in human colon cancer cells through PKC delta/NF-kappa B. J Biol Chem, 2003, 278:51091-51099.
  • 8Hegde R, Srinivasula SM, Datta P, et al. The polypeptide chain-releasing factor GSPT1/eRF3 is proteolytically processed into an IAP-binding protein. J Biol Chem, 2003, 278: 38699-38706.
  • 9Das R, Mahabeleshwar GH, Kundu GC. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling paathways in breast cancer cells. J Biol Chem, 2003, 278:28593-28606.
  • 10Koukourakis MI, Giatromanolaki A, Brekken RA, et al. Enhanced expression of SPARC/osteonection in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. Cancer Res, 2003, 63: 5376-5380.

共引文献15

同被引文献59

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部